Perinatal OCD is common but often missed by depression-only screens. Adding perinatal-specific anxiety and OCD tools can improve detection and guide targeted treatment.
Women with PMOS have significantly higher rates of depression and anxiety. Routine screening and integrated care are essential for improving psychiatric and reproductive outcomes.
Current data suggest that SSRI antidepressants do not meaningfully reduce IVF success, while untreated depression or anxiety may be associated with lower pregnancy and live birth rates.
Sleep disturbance is common in peri- and postmenopausal women, even in the absence of VMS, and is independently linked to worse quality of life, depression, and anxiety.
How should psychiatrists think about hormone therapy in perimenopause? This article explains when, why, and how to consider MHT for perimenopausal women with mood and anxiety symptoms.
A new study examines why some women continue using cannabis during pregnancy, revealing overlapping motives such as mental health, relief of nausea and vomiting, and pain management.
Lavender, used historically for anxiety, stress, depression, and sleep, may provide benefits through aromatherapy or oral forms. Evidence supports potential effects, though safety and efficacy in pregnancy and breastfeeding remain unclear.
Behavioral activation intervention, whether delivered by specialists or non-specialists, was effective for the treatment of perinatal depression and anxiety.
Women with premenstrual mood disorders face significantly higher risk of suicidal ideation and behavior, highlighting the need for careful assessment and targeted prevention.
The relationship between breastfeeding and postpartum depression is complex and bidirectional, with each influencing the other through biological, psychological, and social factors.
